Delivery Order SPE2DB20D2104-SPE2DB24FQ91B

Award Date 10/26/23
Potential Completion Date 10/27/23
Potential Value $1.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BOOSTRIX TDAP vaccine syringes (0.5 mL) to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $1,583.80, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed-price pricing type, and the ultimate completion date is April 16, 2024. The contract is not designated as a set-aside and was...
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,277.15. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $4,163.57. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,430.99 and an ultimate completion date of October 17, 2023. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated with a set-aside....
This federal contract award is for the delivery of BOOSTRIX TDAP vaccine syringes to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $3,557.75 and an ultimate completion date of October 24, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 24, 2025 with a ceiling value of $49,910.07. The contract has a firm fixed price and an ultimate completion date of February 25, 2025. The contract is a delivery order and is not associated with a set-aside...
This federal contract award is for the delivery of BOOSTRIX TDAP vaccine syringes (0.5ml) to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,441.11, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 6, 2024 and is a firm fixed-price delivery order. This award is a task order under a larger Indefinite Delivery Contract...
This federal contract award is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). The contract has a ceiling value of $5,438.16 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 18, 2024. The contract was awarded without any...
This federal contract award is for the delivery of Boostrix TDAP vaccine syringes, 0.5mL, to the Defense Logistics Agency (DLA). The contract, valued at $25,492.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGEs, 0.5ML in quantity, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 3, 2025 for a ceiling value of $1,330.50. The contract is a Firm Fixed Price Delivery Order with a completion date of February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FQ91B
    Delivery Order

This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $1,274.60, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc.

The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:17 PM